Immune cells make flexible choices
October 22, 2012 in Immunology
Our immune system must be tremendously complex to respond to the unending assault of viruses, bacteria and cancerous cells. One of the mechanisms used by the immune system to cope with the huge variety of possible threats is to randomly combine DNA segments for the production of receptors on lymphocytes – a type of white blood cell. The number of possible receptors that can be produced in this way is about 1000 times the number of stars in our galaxy – one followed by 15 zeroes. And yet, the actual array of receptors produced does not conform to this picture of random chance: Some receptors are produced at a higher rate than others. New research at the Weizmann Institute can help explain how the immune system maintains its complexity while giving preference to certain receptors.
The research team headed by Dr. Nir Friedman, including postdoctoral fellows Drs. Wilfred Ndifon and Hilah Gal, together with Prof. Ruth Arnon and Dr. Rina Aharoni, all of the Immunology Department, looked at the DNA sequences for receptors in immune cells called T lymphocytes. These receptors identify disease agents so they can be destroyed by the immune system. The genetic sequences encoding these receptors are each composed of three random DNA segments – something like the random lineups in a slot machine. Each of those segments is taken from a different area of the lymphocyte cell genome; each area has a full "menu" of segments to choose from. The assembly of the sequence takes place when the DNA strand folds, bringing a segment from the first area close to those in the second and third areas. The sequence is then cut and pasted together, and the excess bits of DNA in between discarded, thus creating a new and unique genetic sequence for the receptors in each lymphocyte cell.
In a study that appeared recently in the Proceedings of the National Academy of Sciences (PNAS), the team used a system they developed based on advanced high-throughput sequencing techniques to investigate the genetic sequences of an entire array of lymphocyte receptors in mice. With this "panoramic view," the researchers were able to assess how widespread each receptor was and even to suggest a reason for the uneven distribution. It appears that the secret is in the pieces of DNA that eventually get discarded: Both the length of these segments and their flexibility – a function of the protein "packaging" that gives them shape – determine how likely it is that two distant segments will meet.
With this insight, the researchers created a model that can predict the production distribution of receptors based on the distance between segments and the flexibility of the DNA. They then looked at small groups of individuals – up to five – to see if they could find common lymphocyte receptor sequences among them. Surprisingly, the team discovered that a group of five was more likely to all share a common sequence than smaller sub-groups. That may seem like saying there is a higher chance of winning at the slot machine five times in a row than twice, but the scientists can explain this finding based on the preferences revealed. The common sequences may simply be situated in the genome in such a way that they are more likely to be integrated into the receptor sequences. Such sequences may have been selected by evolution for their ability to fight common disease agents or prevent autoimmune disease.
Friedman: "While our immune system often seems to rely on 'luck' to produce random receptors against a long list of threats, the shared receptors suggest that this mechanism is finely tuned to ensure a response to common diseases."
More information: www.pnas.org/conte… 9/15865.long
Journal reference:
Proceedings of the National Academy of Sciences
Provided by
Weizmann Institute of Science
-
Humans, sharks share immune-system feature
Sep 30, 2011 |
not rated yet |
0
-
How unchecked alarms can spark autoimmune disease
Nov 29, 2011 |
not rated yet |
0
-
Transgenic mice with with highly effective components of the human immune system
Aug 09, 2010 |
not rated yet |
0
-
Blood cancer cells initiate signalling cascade
Aug 13, 2012 |
not rated yet |
0
-
When it comes to the immune system, we're all more alike than previously thought, study finds
Sep 01, 2010 |
not rated yet |
0
-
Dipole term in multipole expansion
4 hours ago
-
Bubbles in a Pre-Boiling/Boiling pot of water
5 hours ago
-
Assumptions of Griffith's fracture theory
16 hours ago
-
Current leading voltage or vice versa concept
17 hours ago
-
Angular Frequency of AC voltage
20 hours ago
-
Modeling Rigid Body - Unsure about Euler angles and angular velocity
21 hours ago
- More from Physics Forums - Classical Physics
More news stories
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Immunology
May 20, 2013 |
4.7 / 5 (19) |
8
|
Vitamin D could provide new and effective treatments for asthma
(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...
Immunology
May 20, 2013 |
5 / 5 (1) |
0
|
Immune protein could stop diabetes in its tracks
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
Immunology
May 20, 2013 |
5 / 5 (5) |
0
|
Stem-cell-based strategy boosts immune system in mice
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, ...
Immunology
May 16, 2013 |
4.8 / 5 (5) |
0
|
Resistance to visceral leishmaniasis: New mechanisms involved
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 ...
Immunology
May 16, 2013 |
not rated yet |
0
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Small cancer risk following CT scans in childhood and adolescence confirmed
The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...
Life expectancy gap widens between those with mental illness and general population
The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...
Dietary advice on added sugar is damaging our health, warns heart expert
Dietary advice on added sugar is damaging our health, warns a cardiologist in BMJ today. Dr. Aseem Malhotra believes that "not only has this advice been manipulated by the food industry for profit but it is actually a risk ...
Failure to use linked health records may lead to biased disease estimates
Failure to use linked electronic health records may lead to biased estimates of heart attack incidence and outcome, warn researchers in a paper published in BMJ today.
Iodine deficiency during pregnancy may adversely affect children's mental development
A study of around 1,000 UK mothers and their children, published in The Lancet, has revealed that iodine deficiency in pregnancy may have an adverse effect on children's mental development. The research raises concerns that t ...